IndraLab

Statements


| 7

reach
"Animal studies demonstrated that USP20 depletion significantly inhibited tumor growth and increased the antitumor efficacy of OXA."

reach
"Third, the mechanism by which USP20 promotes tumor progression in this review has been elucidated in a few types of cancer cells, but the mechanism is unclear in most cancer cell lines that highly express USP20."

reach
"USP20 may promote tumor metastasis and is associated with immune infiltration and drug resistance in CRC."

reach
"USP20 can support progression of variety of tumors."

reach
"It is found that knockdown of USP20 significantly reduced tumor growth and increased the antitumor efficacy of OXA (5 mg/kg, twice a week) 20 in vivo (Figure S2D)."

reach
"It has been confirmed that USP20 can cause D2, HIF-1α, β2-AR, TRAF6, Tax and PKM2 to deubiquitinate, thereby regulating thyroid hormone activation, cell cycle regulation, inflammatory response, tumori[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"

reach
"We speculate that USP20 may promote tumor progression by promoting lymph node metastasis."